all news

MBI welcomes 6 new startup companies

December 14, 2023 / blog

Yesterday, MBI welcomed a total of six new startup companies to our incubator community!

When a new company moves in and settles into their lab space, MBI will host a welcome party for them to introduce them to the rest of the companies within our incubator. With activity at MBI picking up, we were able to host a group party for not one, not two, but SIX new startup companies! This growth is a testament that the Central Massachusetts BioCluster is growing and attracting companies of all sizes. We are so exited to welcome new groups into our space and are excited to help them along their startup journey.

Here are some pictures from our event where we also added company ornaments to our Christmas tree:

Group photo: Some of our current startups with new companies AAVinue, Inc., uBriGene, Splice Histology, Ethos Laboratories, Pananosis, and NHPRR.

uBriGene: uBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in the development and application of cell and gene therapy technologies.

AAVinue, Inc.: AAVinue, Inc. is a pre-seed stage biotech startup, pioneering development of advanced AAVs (adeno-associated viruses) capable of evading neutralizing antibodies and providing deep tissue penetration to allow increased patient access to life-saving therapies.

Ethos Laboratories: Ethos is a CAP-accredited, CLIA-certified, high-complexity laboratory that specializes in the highest quality diagnostic testing including clinical toxicology, biomarker testing, pharmacogenetics, serology, and infectious disease testing.


Non Human Primate Reagent Resource (NHPRR): NHPRR supports innovation, reproducibility, and translation of preclinical research with high-quality biologics development.

Splice Histology